ArticleAmerican journal of cancer research2025
Synergistic therapeutic effects of pertuzumab and pyrrolitinib in HER-2-positive breast cancer: modulation of the PI3K/AKT pathway.
Xiaochao Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.